Novel approaches to detect serum biomarkers for clinical response to interferon-beta treatment in multiple sclerosis.

PLoS One · 2010 · PMC2864746 · PMID 20463963

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

CR also showed a trend towards a higher percentage of samples with detectable serum IL-6, another Th2 cytokine.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.